Literature DB >> 12172038

Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea.

Duk-Hee Lee1, Jin-Ha Kim, Jung-Ja Nam, Hye-Reon Kim, Hai-Rim Shin.   

Abstract

The purpose of this study was to investigate the epidemiological characteristics of hepatitis B virus (HBV) infection in Korea based on the 1998 National Health and Nutrition Survey. Study subjects consisted of 9,771 aged 10 yr or over, who were selected from across Korea using a stratified multistage probability sampling design. The prevalence of hepatitis B surface antigen (HBsAg) was compared by age, sex, residency, household income, education, family history, family size, and frequency of eating out. The prevalence of HBsAg was 5.1% (95% confidence interval (CI): 4.5-5.7) in males and 4.1% (95% CI: 3.6-4.6) in females with a low prevalence in those under 20 yr old. Generally, HBsAg seropositivity by administrative area was similar with the exception of Jeju province. HBsAg seropositivity of Jeju island was approximately three times higher in both men and women, as compared with the national average. HBsAg seropositivity by socioeconomic status unexpectedly showed a very consistent positive association in both gender. Comparing HBsAg seropositivity by the frequency of eating out, in both gender, the more frequent they ate out, the higher it was. Our study suggested that there might be another transmission route of HBV, which is possibly related to diet.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172038      PMCID: PMC3054913          DOI: 10.3346/jkms.2002.17.4.457

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  38 in total

1.  Hepatitis B prevention and control: Lessons from the East and the West.

Authors:  Monica C Robotin
Journal:  World J Hepatol       Date:  2011-02-27

2.  Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B.

Authors:  Suk Bae Kim; Il Han Song; Young Min Kim; Ran Noh; Ha Yan Kang; Hyang Ie Lee; Hyeon Yoong Yang; An Na Kim; Hee Bok Chae; Sae Hwan Lee; Hong Soo Kim; Tae Hee Lee; Young Woo Kang; Eaum Seok Lee; Seok Hyun Kim; Byung Seok Lee; Heon Young Lee
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

3.  Prevention by Lamivudine of hepatocellular carcinoma in patients infected with hepatitis B virus.

Authors:  Heon Ju Lee; Ryul Eun; Byung Ik Jang; Tae Nyeun Kim
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

4.  Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.

Authors:  Neung Hwa Park; Il Han Song; Young-Hwa Chung
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

5.  The prevalence of hepatitis C virus infection in Korea: pooled analysis.

Authors:  Hai-Rim Shin; Soon Young Hwang; Chung-Mo Nam
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

Review 6.  Hepatitis B virus mutations related to liver disease progression of Korean patients.

Authors:  Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

7.  Hepatitis B infection among adults in the philippines: A national seroprevalence study.

Authors:  Stephen N Wong; Janus P Ong; Madalinee Eternity D Labio; Oscar T Cabahug; Maria Lourdes O Daez; Erlinda V Valdellon; Jose D Sollano; Marilyn O Arguillas
Journal:  World J Hepatol       Date:  2013-04-27

8.  Hepatitis B vaccinations among Koreans: Results from 2005 Korea National Cancer Screening Survey.

Authors:  Hee-Soon Juon; Kui Son Choi; Eun-Cheol Park; Min-Son Kwak; Sunmin Lee
Journal:  BMC Infect Dis       Date:  2009-11-25       Impact factor: 3.090

Review 9.  Current antiviral therapy for chronic hepatitis B.

Authors:  Young-Suk Lim; Dong Jin Suh
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

10.  Seroprevalence of hepatitis B virus among health care workers in Korea.

Authors:  Bo-Moon Shin; Hyeon Mi Yoo; Ae Sook Lee; Sang Keun Park
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.